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Abstract: Flexible wearable chemical sensors are emerging tools which target diagnosis and 
monitoring of medical conditions. One of the potential applications of wearable chemical sen-
sors is therapeutic drug monitoring for drugs that have a narrow therapeutic range such as lith-
ium. We have investigated the possibility of developing a fibre-based device for non-invasive 
lithium drug monitoring in interstitial fluid. A flexible cotton-based lithium sensor was coupled 
with a carbon fibre-based reference electrode to obtain a potentiometric device. In vitro reverse 
iontophoresis experiments were performed to extract Li+ from under porcine skin by applying a 
current density of 0.4 mA cm-2 via two electrodes. Carbon fibre-based reverse iontophoresis 
electrodes were fabricated and used instead of a conventional silver wire-based version and 
comparable results were obtained. The fibre-based Li+ sensor and reference electrodes were 
capable of determining the Li+ concentration in samples collected via reverse iontophoresis and 
the results compared well to those obtained by ion chromatography. Additionally, biocompatibil-
ity of the used materials have been tested. Promising results were obtained which confirm the 
possibility of monitoring lithium in interstitial fluid using a wearable sensor.  
 
Keywords: Ion-selective electrodes, non-invasive wearable sensors, reverse iontophoresis, lith-
ium drug monitoring, interstitial fluid, biocompatibility.   
1. Introduction 
Wearable sensors are exciting emerging screening tools which are undergoing active develop-
ment (Heikenfeld et al. 2018). Many physical wearable sensors have been developed for moni-
toring of a patient’s physiological status, such as temperature, (Webb et al. 2013) heart rate 
(Zhang et al. 2010) or respiration rate (Reinvuo et al. 2006). While wearable glucose monitors are 
currently being marketed, few other commercial wearable chemical sensors exist. Using wearable 
chemical/biochemical sensors at home instead of a traditional clinical setting for screening or 
follow up would help to reduce the burden on health professional’s time such as phlebotomists 
and nurses. In addition, home and non-invasive monitoring would be friendlier for patients and 
carers, reducing stress due to blood sampling and time/travel associated with attendance to clin-
ical settings. Such analysis would also be available to a wider patient base including those with 
poor access to a clinical setting. In addition, non-invasive, home monitoring can facilitate earlier 
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diagnosis and improved therapeutic monitoring, which may result in better health care, and ther-
apy outcomes thereby improving the quality of life for many people. 
Many patients need to monitor their medical condition regularly during treatment. It is estimated 
that bipolar disorder affects 1 in 100 people (Merikangas and Peters 2010). Lithium remains the 
most effective long-term therapy for bipolar disorder. Lithium monitoring is essential due to its 
narrow therapeutic range (0.4 – 1.0 mM) and the toxicity associated with drug-levels above this 
range (Logan and Main 2013). Bipolar disorder patients need to initially monitor their lithium drug 
plasma level on a weekly basis then monthly and then every 3 months while treatment with this 
drug continues (Logan and Main 2013). Lithium is currently quantified in laboratories using atomic 
spectroscopy and an ion-selective analyser (Christian 1996; Diazyme 2015). A blood sample is 
taken by a healthcare professional 12 hours after the most recent dose of lithium taken by the 
patient.  The high frequency of invasive blood sampling leads to poor patient compliance which 
puts the patient at risk of gastrointestinal and nervous system drug toxicity or even death due to 
the narrow therapeutic range of lithium (Logan and Main 2013). A non-invasive method for meas-
uring drug levels would facilitate monitoring (Djabri et al. 2015) and improve patient outcomes.  
Reverse iontophoresis (RI) is one method which has been explored to offer non-invasive thera-
peutic drug monitoring (Leboulanger et al. 2004c).  RI facilitates the extraction of ions and non-
charged species from under the skin via the application of a small current between two electrodes 
on the skin (Santi and Guy 1996). Under the effect of this current, ions in the subdermal layer 
migrate across the skin to the surface where the electrode of opposite charge is located.  Extrac-
tion of drugs such as sodium valproate (Delgado-Charro and Guy 2003), phenytoin (Leboulanger 
et al. 2004d), amikacin (Nicoli and Santi 2006) and lithium (Leboulanger et al. 2004a; Leboulanger 
et al. 2004b; Wascotte et al. 2005) using this non-invasive RI technique has been reported. These 
studies demonstrated the proof of concept for non-invasive sampling using transdermal iontopho-
resis, but the collected samples still needed to be sent to a laboratory for analysis. To the best of 
our knowledge, no study has reported monitoring of therapeutic drugs using a wearable sensor. 
Fibre-based wearable chemical sensors were previously developed for the determination of pH, 
K+ and NH4+ (Guinovart et al. 2013) and Na+ (Parrilla et al. 2016). These sensors required condi-
tioning in a solution of the ion of interest overnight before first use and then for at least 15 mins 
before each subsequent use. We succeeded in excluding this conditioning step for wearable ion-
selective electrodes in our previous work (Sweilam et al. 2018). The exclusion of the pre-condi-
tioning step makes the sensor suited to wearable applications. Another consideration for any 
wearable sensor is the bio-compatibility of the materials used (Williams 2014).  
Here we follow on from our previously reported work and combine a lithium sensor fibre and 
reference fibre, which can be used without any pre-conditioning step, giving a miniaturised poten-
tiometric cell that can be incorporated in a dermal patch. We report on the performance of an 
additional set of fibre-based reverse iontophoresis electrodes in extracting lithium ions from under 
the skin. The extracted lithium ion concentration was subsequently determined using the minia-
turised sensor device and compared to analysis using ion chromatography as a reference 
method. The cytotoxicity of the sensors materials was also investigated as a primary indication of 
biocompatibility.   
2. Methods  
 
2.1. Reagents and solutions  
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Commercially available carbon fibres (CNF) (93% purity, 6.4 mm length, 0.08 mm diameter) were 
purchased from Alfa Aesar (Heysham UK). Single-walled carbon nanotubes (SWCNTs >70% car-
bon purity), were obtained from Nanocyl (Belgium) and used directly without any purification.  
Lithium ionophore VI (6,6-Dibenzyl-14-crown-4), lithium tetrakis(pentafluorophenyl) borate ethyl 
etherate (LiTPFPB), trioctylphosphine oxide (TOPO), 2-nitrophenyl octyl ether (NPOE, >99% pu-
rity), high molecular weight poly(vinyl chloride) (PVC), Butvar® B-98 , methanol (anhydrous 
99.8%), tetrahydrofuran, sodium dodecylbenzenesulfonate (SDBS), Ag wire (99.999 %), platinum 
wire (99.99+%), AgCl salt (99.999 %) and analytical grade of NaCl, KCl, LiCl salt, Tris base, po-
tassium gluconate (anhydrous), MgCl2 salt and CaCl2 were all purchased from Sigma-Aldrich 
(UK). Di-sodium hydrogen orthophosphate anhydrous and potassium dihydrogen orthophosphate 
were purchased from Fisher scientific (UK). Ag/AgCl ink (60/40, C2130809D5) purchased from 
GWENT part of SunChemical (Torfaen, UK). Cotton thread was purchased from the local shop. 
Human plasma mixed pool product was purchased from TCS Biosciences Ltd (Buckingham UK). 
Human keratinocyte cell line (HaCaT) (300493, CLC, Germany), Alamar Blue® (Thermofisher 
Scientific, UK), Dulbecco’s Modified Eagles Medium (DMEM, D6546, Sigma, UK) were used for 
the biocompatibility assay. Ultrapure water (18.2 MΩ cm) was used throughout this study. 
 
2.2 Fabrication of the lithium sensor and reference electrode. A cotton fibre-based lithium 
sensor (CF-Li+) was fabricated by first dipping 5 mm of a cotton thread in SWCNT ink for 5 cycles. 
A cycle was composed of dip, dry, wash then dry.  Following these 5 cycles, the resulting conduc-
tive cotton fibre (dry) was dipped 9 times in lithium membrane solution (Sweilam et al. 2018). The 
lithium membrane solution was composed of 28 wt % PVC, 68.5 wt% NPOE, 1.5 wt% Li ionophore 
VI, 0.5 wt % LiTPFPB and 1.5% TOPO. After drying overnight, the resulting sensor could be used 
directly without preconditioning. A CNF-based reference electrode was fabricated using a 5 mm 
length of carbon fibre, which was dipped twice in Ag/AgCl ink and cured in an oven at 90 ˚C for 
30 min after each dip (CNF-SI). The silver-coated carbon fibre was subsequently dipped 5 times 
in a reference membrane solution (RM) to give the final reference electrode (CNF-Ref), which 
was used directly without any conditioning protocol.  The RM solution was composed of 78.1 mg 
of PVB and 50 mg of NaCl dissolved in 1 ml of anhydrous methanol. 
 
2.3 Potentiometric measurements. An eDAQ potentiostat/galvanostat (ModelEA161) in high z 
mode and eDAQ e-corder 410 were used to measure the difference in potential between two 
electrodes. CF-Li+ and CNF-Ref potentials were recorded against a double junction reference 
electrode (DJRE) Ag/AgCl/KCl (3.0 M KCl) reference electrode part number 6.0726.100, 
Metrohm, UK, containing aqueous KCl (0.1 M) electrode bridge electrolyte. The total ionic strength 
and the liquid junction potential was calculated for each calibration point using the Henderson 
equation. LiCl samples of different volumes were measured using the fabricated lithium sensor 
CF-Li+ against the fabricated reference electrode CNF-Ref. The Debye-Huckel formalism was 
used to calculate the activity coefficients. 
 
2.4 Reverse iontophoresis (RI) experiment. A piece of abdominal dermatomed porcine skin 
was washed, cleaned and prepared for use in iontophoresis experiments. The skin thickness was 
approximately 750 µm.  The skin was stored at -20 ˚C. Franz two-compartment cells were used 
with 2.0 cm2 pig skin surface area. The subdermal, anode compartment was filled with 7.4 mL of 
LiCl (0.2 – 3.0 mM) in PBS (phosphate buffer containing 154 mM NaCl, pH 7.4). Each cathode 
compartment was filled with 0.3 ml of 30 mM potassium gluconate solution. A constant current of 
0.8 mA was applied via reverse iontophoresis electrodes (current density = 0.4 mA cm-2) using a 
KEPCO power supply APH 1000 DM. Carbon-fibre-based reverse iontophoresis electrodes (CNF-
RI) were fabricated by a single dip in a Ag/AgCl ink to form a uniform coating of Ag/AgCl then 
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cured in an oven at 90°C for 30 min. RI experiments started with a 30 min warm-up period, fol-
lowed by a 2 h reverse iontophoresis lithium extraction step. At the end of the experiment, solu-
tions in the cathode compartments were collected and analysed using the fabricated sensors and 
ion chromatography. Standard Ag/AgCl wire-based RI electrodes were fabricated for comparison 
purposes, details of which are provided in the supporting information (Cordery et al. 2019). 
 
2.5 Ion chromatography analysis. Lithium samples were quantified by ion chromatography. The 
Dionex ICS 5000 instrument was equipped with a Dionex™ IonPac® CS16 (3 x 250 mm) cation-
exchange IC column (carboxylate functionalised), CSRS suppressor and Dionex™ EGC III MSA 
Methane Sulfonic Acid Eluent Generator Cartridge. 30 mM methane sulfonic acid was used with 
a flow rate of 0.360 ml min-1 and sample injection volume of 20 µl. A retention time of 4.5 min was 
obtained. 
 
2.6 Biocompatibility study. Cell viability studies were performed, in order to investigate the bio-
compatibility of the CF-Li+, CNF-Ref and the individual constituents of the CNF-Ref (CNF-SI, CNF 
and RM). Specimens of the active 5 mm of electrodes were cut from the rest of cotton/carbon 
fibres.  For sterilisation purposes, the CF-Li+ sensor, the CNF and the CNF-SI were dipped in 
ethanol for 3h, air-dried and then sterilised for 10 min in a UV/ozone generator (BioForce Nano-
sciences), while the whole CNF-Ref and the RM alone were sterilised with the UV/ozone gener-
ator for 15 min, without ethanol sterilization as the RM dissolved in the ethanol solution.  The 
HaCaT was plated in 96-well plates at a plating density of 104 cells/well and allowed to adhere 
on the surface for 24 h in a humidified atmosphere of 5% CO2 and 20% O2 at 37 C. Afterwards, 
the sensor specimens were added to each well. Control samples without the sensors were also 
generated. The cell viability was assessed using Alamar Blue® assay, which incorporated an ox-
idation-reduction resulting in a color change of the culture according to the cell growth. This assay 
has negligible toxicity, therefore enables the use of the same HaCaT samples multiple times. 
Sensor specimens were incubated with the Alamar Blue dye diluted in the cell culture medium 
according to the manufacturer’s instructions for 1.5 h at different culture time points, 1, 3 and 5 d 
post sensor administration on the cells. The absorbance was measured with a spectrophotometer 
(Synergy, BioTek, VT, USA) at 570 nm and at 600 nm, as a reference wavelength. Finally, the cell 
viability was calculated using the dye molar extinction coefficients and appropriate absorbance 
equations provided by the manufacturer.  Optical micrographs of the HaCaT cells in the presence 
of the sensors on day 1 and day 5 were taken using an inverted phase-contrast microscope with 
a 10 times dry objective (Axiovert 40, Zeiss, US).  Statistical analysis was performed from N = 3 
independent experiments with at least triplicate measurements (n = 3) per experiment. Analysis 
of variance (Two-way ANOVA) was performed using Graph Pad Prism® software with a p-value 
threshold of 0.05 to evaluate whether there was a statistical difference between the experimental 
conditions.  
3. Results and discussion  
3.1 Fabrication of CF-Li+ and CNF-Ref electrodes. A CF-Li+ thread-based sensor was made 
as previously reported by coating a cotton thread with SWCNT ink and a lithium-selective mem-
brane (Sweilam et al. 2018). Figure S3 (supporting information) shows an image of the final fibre 
sensor. A trial to fabricate a pseudo-reference electrode on a commercially available carbon fibre 
was carried out according to Parrilla et al. (Parrilla, et al. 2016). It involved dipping 5 mm of the 
carbon fibre in Ag/AgCl ink, followed by oven curing.  Carbon fibres dipped twice in Ag/AgCl ink 
and cured were subsequently coated with a reference membrane comprised of PVB and NaCl; 
CNF-Ref (image available in Figure S3 (supporting information)). The potentiometric response of 
CNF-Ref was measured against the DJRE in 0.1 - 63.0 mM LiCl and a slope of -0.1 mV ± 1.5 mV 
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dec−1 was achieved which is comparable to the reported study (-0.19 mV decade-1). SEM char-
acterisation was carried out to determine the distribution of the coated fibres. A cross section 
through the CNF-Ref electrode showed an inner CNF diameter of 270 µm, a Ag/AgCl film thick-
ness of 460 µm and an outer membrane thickness of 96 µm as shown in Figure S1 (supporting 
information). Further characterisation of this fibre reference electrode was performed using EDX 
analysis to investigate if the coated layers overlapped or whether they remained separate from 
each other. Figure S2 (supporting information) shows EDX elemental mapping in CNF-Ref. Well 
defined, separated layers of CNF, Ag/AgCl and RM are evident. 
 
The CNF-Ref electrode could be used directly without pre-conditioning in contrast to the reference 
electrode developed in Parrilla et al. (Parrilla, et al. 2016) which needed a long overnight condi-
tioning before being used. Conductive cotton-fibres (cotton thread coated with SWCNTs) were 
tested in place of the inner carbon fibre in CNF-Ref and results showed no advantage in using 
conductive cotton over carbon fibre.  For the sake of simplicity, CNF were selected to build refer-
ence electrodes on. The CNF-Ref electrode took less than 1 min to stabilise after its first contact 
with solution after which it responded within 20 s.   Figure 1 (left) shows the response of four 
replicate CF-Li+ sensor electrodes and CNF-Ref electrodes against a DJRE with slopes of 59.9 
± 0.6 mV dec-1 and -0.1 ± 0.6 mV dec-1 respectively. There is clearly a larger variation in the 
reproducibility of CNF-Ref electrodes compared to CF-Li+ sensor electrodes. Further work is re-
quired to improve the response and reproducibility of CNF-Ref electrodes. 
 
3.2 Potentiometric measurements on miniaturised fibre-based device (CF-Li+ connected to 
CNF-Ref). Each of the four CF-Li+ fibre sensors were randomly connected to a CNF-Ref electrode 
and will be referred to as Li+-Ref device. The randomly paired Li+-Ref devices were tested in LiCl 
solutions over a concentration range of 0.1 - 63 mM. Good Nernstian responses were obtained 
using Li+-Ref devices with little variation between replicate measurements as can be seen in 
Figure 1 (right) with an average slope of 57 ± 1 mV dec-1 which maintains a good Nernstian 
response and compares well to the average response of CF-Li+ sensor electrodes against DJRE; 
59.9 ± 0.6 mV dec-1 (Figure 1 left). The % RSD of the standard potential (as indicated by the 
intercept) for the 4 replicate Li+-Ref devices is 3 % which compares well to the % RSD of the 
intercept of CF-Li+ sensor electrodes (n = 4) obtained against DJRE (RSD = 1.7 %).  The LOD 
was found to be 10-5 M.
   
Figure 1: Left: The average potentiometric response of replicate CF-Li+ & CNF-Ref electrodes vs. Ag/AgCl 
DJRE.  Right: The average potentiometric response of replicate Li+-Ref devices. All measurements were 
performed in 25 ml of aqueous LiCl solution over a concentration range of 0.1 – 63 mM, n = 4.
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The slope of the Li+-Ref device (57 ± 1 mV dec-1) was comparable to the slope obtained for a 
miniaturized paper-based lithium device reported by Novell et al. (Novell et al., 2014); slope = 57 
± 2 mV dec-1. The main advantage of our device is the possibility to use it without the need for a 
conditioning protocol while the device reported by Novell et al. needed an overnight conditioning 
protocol before the first use and a 20 min conditioning before any subsequent use. 
  
Potentiometric measurements up to this point were carried out using a sample volume of 25 ml.  
Reduction of the sample, to volumes at the microlitre scale, was essential for the intended wear-
able applications. The Li+-Ref devices were tested in different sample volumes ranging between 
50 – 300 µl and the response obtained was compared to those achieved in 25 ml samples. The 
average slopes calculated for all the devices in different samples volumes ranged between 55.6 
– 59.4 mV dec−1. The Li+-Ref devices responded in a similar manner to all sample volumes tested 
(50, 100, 200 and 300 µl), while the highest precision was achieved with a sample volume of 0.3 
ml. The results shown in Figure 2 confirm the ability of the Li+-Ref devices to respond to Li+ 
concentration changes in a similar manner even with a minimal sample volume. Further optimi-
sation is however required to increase the resiliency of the fibre-based reference electrodes to 
differences in chloride concentration, which gives rise to changes in the electrode standard po-
tential. The devices therefore require calibration before use to eliminate such differences in stand-
ard potential between devices. 
 
Figure 2: The average potentiometric response of the Li+-Ref device measured in two different sample 
volumes over a concentration range of 0.1 – 63 mM. The values on the plots are log (Li+ activity), n = 4 (4 
different devices). 
The ability of the Li+-Ref devices to respond to continuous changes in Li+ concentration was in-
vestigated. Figure 3 shows a rapid and stable response towards LiCl concentration changes, with 
0.3% RSD from one cycle to the next, which is comparable to results obtained in our previous 
publication when using a DJRE (Sweilam et al. 2018).  
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Figure 3: The potentiometric response vs. time of a Li+-Ref device in 0.1 ml of solution when varying the 
concentrations of LiCl solution (concentration range of 0.1 – 63 mM) and after a sudden reduction in Li+ 
concentration. The values on the plots are log (Li+ activity). 
The Li+-Ref devices were tested in human plasma since it is the most similar biological matrix to 
interstitial fluid in terms of composition. The human plasma samples were spiked with different 
concentrations of LiCl and the potentiometric response was measured. Figure 4 shows very prom-
ising responses for 5 different Li+-Ref devices towards Li+ concentration changes in plasma. The 
response of the Li+-Ref device spans the clinically relevant therapeutic range and into the clini-
cally toxic range. The results were comparable to measurements of a CF-Li+ sensor fibre in LiCl 
spiked plasma samples against a DJRE, Figure 4. The % Recovery of Li+ concentration using the 
Li+-Ref device was 100 (± 3) % compared to 100 (±1) % when using CF-Li+ sensor against a 
DJRE. These results give a good indication of the capability of the Li+-Ref device to determine 
Li+ concentration in interstitial fluid. 
 
Figure 4: The response of 5 different Li+-Ref devices measuring Li+ concentration change in 0.1 ml spiked 
plasma compared to the response of 3 replicates of CF-Li+ sensors against DJRE. 
3.3 RI experiments. Leboulanger et al. (Leboulanger et al. 2004a; Leboulanger et al. 2004b; 
Wascotte et al. 2005) studied the extraction of Li+ from interstitial fluid via RI. Their study was 
carried out using silver wire-based RI electrodes and 1.5 ml of collecting solution in both the 
cathode and anode compartments. Changes to this experimental set-up are required for wearable 
applications. Two main objectives will be discussed here. First, the selection of the collecting 
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solution electrolyte and the reduction of the collecting solution volume. Second, the replacement 
of silver wire RI electrodes with flexible carbon fibre-based RI electrodes  
 
In the lithium extraction experiment, two-compartment Franz diffusion cells were used. The anode 
compartment acted as the subdermal lithium reservoir while the upper cathode compartment was 
filled with collecting electrolyte. 1.0 ml of KCl, potassium gluconate or Tris buffer were tested as 
collecting electrolyte in the upper cathode compartment to measure their effect on the extraction 
rate. 0.1 ml aliquots of this 1.0 ml solution from each cathode compartment (containing KCl, po-
tassium gluconate or Tris buffer) were analysed using the Li+-Ref device and potentiometry. In 
addition, 20 l of the collected sample was analysed using ion-chromatography and the results 
were compared to those obtained from the Li+-Ref device. Figure 5 shows that the maximum 
extraction rate was obtained using a potassium gluconate electrolyte which may be due to the 
difference in size and mobility of Cl- and gluconate anions (gluconate- and Cl- mobility = 2.48 and 
8.06  10-4 cm2 s-1 V-1 (Mudry et al. 2006)).  This is consistent with earlier work on iontophoretic 
transport numbers (Mudry et al. 2006). A paired t-test revealed no significant difference between 
results obtained by the Li+-Ref device and ion-chromatography which indicates that the Li+-Ref 
device is a potential point-of-care alternative to ion-chromatography. 
 
Figure 5: Data of 3 groups of triplicate Franz diffusion cells using 30 mM of different collecting solutions 
(KCl, potassium gluconate (KGlu) and Tris buffer). 
3.4 Replacement of rigid silver wire with flexible CNF-RI electrode. Frequently, a silver wire 
(~6 cm length, 0.5 mm diameter) is used as RI electrode as described in the methodology.  As 
the aim was to fabricate a wearable lithium extraction and sensing system, a silver wire was 
considered inappropriate due to its rigidity and overall dimensions. A flexible fibre-based RI elec-
trode was developed on commercially available carbon fibre using a one-step procedure of dip-
ping the carbon fibre in Ag/AgCl ink followed by curing (Figure S3). To investigate the applicability 
of using CNF-RI electrodes in RI experiments, two sets of triplicate Franz diffusion cells were filled 
with the same subdermal solution concentration (7.4 ml of PBS spiked with 1.5 mM LiCl) and the 
same collecting cathode solution (1.0 ml of 30 mM potassium gluconate). Silver-based RI elec-
trodes were used in one group of the triplicate Franz diffusion cells while in the other group the 
CNF-RI electrodes were used. Figure 6 shows that good agreement in Li+ extraction was achieved 
using the CNF-RI electrode in RI experiments compared to the traditional silver wire. The samples 
collected from the upper cathode compartments were analysed using both the Li+-Ref device and 
ion chromatography and the results obtained were compared to each other. A paired student’s t-
test revealed no significant difference between the lithium extraction fluxes attained with the two 
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methods. The results in Figure 6 also show good agreement between measurements made by 
the Li+-Ref device when compared to results obtained by ion chromatography. 
 
Figure 6: The Li+ flux rate of 2 groups of triplicate Franz cells; 1st group used silver wire-based RI electrodes 
and 2nd group used flexible CNF-RI electrodes.  
Figure 6 shows that both the silver wire RI and CNF-RI electrodes were capable of extracting the 
same amount of Li+ from under the porcine skin and confirm that the replacement of the silver 
wire RI electrodes with carbon fibre-based equivalents did not lead to any significant difference in 
terms of extraction rate. In addition to the flexibility offered by the CNF-RI electrode, the straight 
forward fabrication methodology made it more favourable to use than the silver-based RI elec-
trode. 
 
The Li+-Ref device has a linear response between 0.1 – 63 mM and was capable of determining 
lithium ion concentration changes in sample volumes ranging from 0.1 – 25 ml.  An optimum 
sample volume was selected to enable both the reverse iontophoresis extraction of lithium ions 
and the quantification of lithium ions using the Li+-Ref device.  For the reverse iontophoresis 
experiment, a current density of 0.4 mA cm-2 was applied to 2 cm2 of porcine skin. A sufficient 
volume to cover a 2 cm2 area of skin while maintaining no contact between the RI electrodes and 
the skin was sought.  To allow potentiometric measurements, a minimum sample volume was 
required to meet the quantification limit of the Li+-Ref device. It was theoretically calculated that 
to work within the linear range of the potentiometric cell a volume of less than 0.5 ml was required.  
It was found that the minimum sample volume that could cover the skin and provide no contact 
between the RI electrodes and the skin was 0.3 ml.  
 
3.5 The relationship between subdermal concentrations of Li+ and the extracted concen-
tration. After optimising the collecting solution, the CNF-based RI and the sample volume, in vitro 
investigations into the effect of subdermal LiCl concentration changes were carried out.  Different 
LiCl concentrations (0.2 – 3.0 mM) in PBS acted as subdermal anode solutions. The cathode 
compartment was filled with 0.3 ml of potassium gluconate.  The use of 0.3 ml of potassium glu-
conate as a collecting solution enabled concentrated samples to be collected at the end of the RI 
experiment, which were within the linear dynamic range of the Li+-Ref device. Figure 7 shows the 
linear relationship between the subdermal lithium ion concentration and the extracted lithium ion 
concentration as measured by the Li+-Ref device. The results show a good correlation between 
different subdermal concentrations and the Li+ extracted (via RI) and measured using the Li+-Ref 
device. The Li+-Ref device shows good linearity above 0.8 mM Li+ and further investigation of the 
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non-linearity below 0.6 mM Li+ is required. The usual therapeutic range for lithium blood concen-
tration is between 0.6 – 0.8 mM, with blood tests advised every three months during therapy. 
Monthly monitoring is recommended for levels above 0.8 mM (Haste 2017). The results from 5 
replicate experiments (covering the range of 0.2 – 3.0 mM) show that the Li+-Ref device re-
sponses for 0.8 and 1.0 mM Li+ are significantly different from each other. These initial results 
show that the Li+-Ref device could act as a warning system that Li+ levels over the usual thera-
peutic range had been reached. This initial investigation shows the considerable promise of the 
Li+-Ref device for efficient management of therapeutic lithium. The electrodes developed here 
could be incorporated within a skin patch, with connections available to a miniature potentiostat 
that can deliver wireless electrochemical readouts with smartphones (Kumar Vashist et al. 2015). 
This could facilitate personalized monitoring of lithium drug levels for patients. Further optimisa-
tion of the linear dynamic range of the device may allow better sensitivity within the therapeutic 
range which will enable more accurate and precise measurements of Li+ concentration levels. 
 
 
Figure 7: Calibration of reverse iontophoresis extraction. Samples analysed using the Li+-Ref device. The 
dashed line represents the concentration boundary where three-month testing (LHS) is advised to change to 
monthly testing (RHS). n = 3 – 5. 
3.6 Biocompatibility of the fabricated fibre-based potentiometric cell.  To assess the bio-
compatibility of CF-Li+ and CNF-Ref fibre electrodes, HaCaT cells were cultured in the presence 
of both the CF-Li+ & CNF-Ref fibre electrodes. As can be seen in Figure 8, the cell viability was 
not significantly affected by the CF-Li+ sensor presence (compared to the control) for all the 
culture duration; therefore this sensor appears to be non-toxic for the cells. However, there was 
a significant decrease in cell growth (53%) for the cultures including CNF-Ref fibre electrodes. 
This agrees with the visual observations presented in Figure S4, which indicate the undisturbed 
cell growth for the lithium sensor samples and the reduced number of viable keratinocytes due 
to the presence of the CNF-Ref electrode. In order to further identify the reference sensor’s com-
ponent that triggered the toxicity, HaCaT cultures including the electrodes constituents (CNF, 
CNF-SI and RM) were generated. Figure 8 indicates that the CF and RM are not toxic, while the 
CNF-SI appears to reduce cell viability. It was observed that the coating of the CNF-SI with RM 
decreased the cell toxicity that occurred due to the presence of the silver ink. Many commercially 
available healthcare electrodes safely use silver chloride, therefore the toxicity observed may be 
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due to the incomplete evaporation of methyl carbitol and butyl glycol acetate in the silver chloride 
ink during oven curing. Future investigation of different Ag/AgCl ink is required. 
 
 
Figure 8: Top: Cell viability of HaCaT cells growing with the lithium sensor, the reference sensor and control 
samples 24, 72 and 120 h post sensor administration (N = 3, 3 independent experiment with 3 replicate each).  
Bottom: Cell viability of HaCaT cells growing with the carbon fibre, the carbon fibre coated with silver ink and 
control samples. n = 3. 
4. Conclusions  
This proof-of-concept study highlights the promise of a miniaturised, flexible fibre-based potenti-
ometric cell (Li+-Ref device) for non-invasive therapeutic Li+ monitoring.  The potentiometric cells 
were able to determine Li+ concentration in plasma as a complex biological fluid.  The ability of 
the fibre-based sensors to determine Li+ concentration change in simulated interstitial fluid in vitro 
was confirmed. The extraction of Li+ using flexible fibre-based RI electrodes was carried out.  The 
biocompatibility of CF-Li+ sensor was confirmed while the silver ink used in the CNF-Ref sensor 
showed cytotoxicity.  The possibility of fabricating reference electrodes on carbon fibre which can 
be used directly was examined and the biocompatibility of the CNF and the RM is a good sign for 
the possible usage of these sensors as a wearable sensor. While challenges remain with highly 
sensitive detection in the extremely narrow therapeutic range of this drug, this preliminary proof-
12 
 
of-concept demonstration indicates the potential of fibre-based wearable devices for managing 
Li+ therapy. 
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